COVIDIEN $65.80

up +0.26


21/5/2013 04:21 PM  |  NYSE : COV  |  Industries : Manufacturing / Medical Equipment and Supplies Manufacturing
Last Trade: 65.80
Trade Time: May 21 4:07 PM Eastern Daylight Time
Change: 0.26 (0.40 %)
Prev Close: 65.54
Open: 65.82
Bid: 65.66
Ask: 65.80
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN

ETF Alternatives



People viewing COV also viewed: , , , ,

Competitors

Ticker Name Volume % Change
VCRT VICOR TECHNOLOGIES 138.7K +1.30%
SUTU SUTURA 30.5K +0.75%
AIRW AIRWARE LABS 250.0 +0.50%
AVVH AVVAA WORLD HEALTH CARE 55.6K +0.29%
BOCX BIOCUREX; INC. COMMON STOCK 23.3K +0.20%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
5/8/2013 Clemmer James C Senior Vice President -29,260 $65.41 -54.71%
5/8/2013 Clemmer James C Senior Vice President 12,732 $46.45 31.24%
5/3/2013 HOGAN RANDALL J Director 8 $64.35 0.05%
5/3/2013 BROWN RICHARD G JR Vice President and Controller 15 $64.35 0.03%
5/3/2013 Madaus Martin D Director 8 $64.35 0.14%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (COV), click here.

COV Stock Analysis

  1. It Gets A Little Harder From Here For Covidien

    Expectations are the bigger issue for Covidien, as underlying growth is still pretty good on a relative basis.
  2. Is Controversy About Robot-Assisted Surgery Showing In Intuitive Surgical's Numbers?

    Uncertainty about procedure growth may be opening a window in these often-expensive shares
  3. Pharma Is Doing All The Pulling For Johnson & Johnson

    Although JNJ reported decent earnings and has some major new drugs lined up - downside risk is definitely still present.
  4. AngioDynamics Still Struggling To Get Back On Track

    Ongoing revenue growth struggles and eroding market share is making the deep-value case harder at AngioDynamics.
Free Reports
  1. View the Portfolios of the Worlds Top Investors, FREE!

    Learn from Warren Buffett, George Soros and More!
  2. FREE Options Trading Manual

    If you are new to the options market, this free booklet is designed for you!
  3. 3 Stocks Peter Lynch Would Buy Today

    This new special report identifies 3 stocks based on Lynch’s market-trouncing strategy that could more than double in the next 12 months.
Marketplace
Trading Center